Session Type
Meeting
Search Results for COVID-19
Abstract Number: 18
SHM Converge 2023
Case Presentation: Patient is a 45-year-old female with a history of esophageal reflux and dysmotility, asthma, depression/anxiety, and recent SARS-2-CoV infection (COVID-19) who presented to our hospital 9 months after initial and 3 months after recurrent COVID-19 with headache, dyspnea, and home blood pressures (BP) > 180/100. Patient reported intermittent symptoms for the last 3 […]
Abstract Number: 27
SHM Converge 2023
Case Presentation: This is a 4-year-old previously healthy girl, fully immunized with the exception of COVID-19 immunizations, who was hospitalized after presenting with fevers and fatigue for one week followed by gross hematuria. At the outset of her fevers, she tested negative for COVID-19 using a home antigen test. 4 days prior to admission, she […]
Abstract Number: 54
SHM Converge 2023
Background: Family members and caregivers serve valuable roles at the hospitalized patient’s bedside as emotional support systems, patient advocates, and decision makers (1). Hospital visitation restrictions (such as those implemented during the COVID-19 pandemic) may come at a cost to patient and caregiver perceptions of care quality and patient safety. Congruent with CDC guidelines during […]
Abstract Number: 104
SHM Converge 2023
Background: Physician burnout has been alarmingly high with over 50% of practicing physicians in the U.S. reporting burnout. Of which, general internal medicine displays some of the highest rates. A recent study was published in December 2021 examining the topic of burnout from the perspective of academic hospitalists at Froedtert Hospital and the Medical College […]
Abstract Number: 111
SHM Converge 2023
Background: Venous thromboembolism, in particular, pulmonary embolism (PE), is a significant contributor to morbidity and mortality associated with COVID-19. In comparison to influenza, COVID-19 leads to a more pronounced hypercoagulable state secondary to endotheliopathy and hyperinflammatory state which results in the formation of venous and arterial thrombosis. Based on prior literature, patients with COVID-19 have […]
Abstract Number: 116
SHM Converge 2023
Background: Researchers across the globe have continued their effort in identifying important risk factors for severe COVID-19 infection. Patient demographics including age, race, gender, and certain chronic medical conditions including cardiovascular disease, diabetes, hypertension, and heart failure have been identified as the important risk factors for severity. To simply the risk stratification process, the CHA2DS2-VASc […]
Abstract Number: 120
SHM Converge 2023
Background: COVID-19 pandemic was vital in modifying healthcare delivery systems. This infection has led to variable composite outcomes in patients who have cardiovascular diseases [1,2]. In this study, we aimed to look into the impact of COVID-19 on incidence and outcomes of patients with Acute Myocardial Infarction using a nationally representative sample from the USA. […]
Abstract Number: 121
SHM Converge 2023
Background: Diabetic Ketoacidosis (DKA) is the most common severe acute complication of diabetes, and has shown to be worsened by COVID-191. Several studies have found an association between COVID-19 and worsened outcomes from diabetic ketoacidosis (DKA).2 Vaccination against COVID-19 has led to substantial declines in the frequency, severity, and mortality from acute infection, but little […]
Abstract Number: 141
SHM Converge 2023
Background: The COVID-19 pandemic was one of the biggest threats to human health, affecting health and health care delivery systems at both the individual and institutional level. There have been varied reports about how sociodemographic factors affect outcomes of patient with COVID-19 [1] [2] [3]. In this US claims based study, we analysed discharge data […]
Abstract Number: 144
SHM Converge 2023
Background: Coronavirus-19 (COVID-19), primarily a respiratory virus, can affect multiple organs, including the heart. Cardiac complications can affect 20-30% of COVID-19 patients and lead to worse morbidity and mortality. Cardiovascular complications can include myocarditis, acute myocardial infarction, heart failure, and arrhythmias Myocarditis is a well-known complication among COVID-19 infections, with limited large-scale studies evaluating outcomes […]